spacer
home > pmps > summer 2017 > digital world
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Digital World

The aim of regulatory standards is to minimise danger for patients and maximise product quality and safety through compliance. For instance, the EU’s EudraLex Volume 4 Good Manufacturing Practice (GMP) guidelines and the FDA’s 21 CFR Parts 210 and 211 describe the best production practices for medicinal products. Furthermore, EudraLex Annex 11 and 21 CFR Part 11 lay down the demands for computerised systems used as part of GMP-regulated activities. These systems are expected to be validated (the GMP-application) and respectively qualified (the GMP-IT infrastructure).

Official Industry Standards

How a pharmaceutical company goes about ensuring that the IT requirements for operational reliability, stability, business support and product quality are met is up to them, but major industry standards are pragmatic and can be used to conform to the law. Some of these are highlighted below:

GAMP 5
The International Society for Pharmaceutical Engineering’s Good Automated Manufacturing Practice (GAMP®) 5: A risk-based approach to compliant GxP computerised systems is the de facto voluntary standard for businesses active in regulated industries such as pharma, biotechnology, medical technology and their associated suppliers. GAMP 5 guidance provides a pragmatic and effective framework for achieving computerised systems that are fit for intended use and meet current requirements.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Léon van Deurse is Senior Consultant at Chemgineering and has been working in IT for over 25 years. He has hands-on implementation experience with the top five ERP systems and how they can support business processes. As an IT Auditor, Léon has dealt intensively with financial IT audits of ERP systems. 
spacer
Léon van Deurse
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

STA Pharmaceutical to open new transition metal catalysis center in Changzhou, China

STA Pharmaceutical, a WuXi AppTec company, has announced plans to launch a new transition metal catalysis center at their integrated API process R&D and manufacturing site in Changzhou China.
More info >>

White Papers

Advances in Aseptic Blow-Fill-Seal Processing of Pharmaceutical Liquids Improve Product Integrity and Patient Safety

Weiler Engineering, Inc

The latest improvements in aseptic blow-fill-seal technology are providing more streamlined automation of critical B/F/S processing areas, while limiting human intervention and effectively reducing airborne microbial bioburden and particulate levels, and enhancing sterility assurance and patient safety.
More info >>

 
Industry Events

3D Cell Culture 2018

21-22 February 2018, Holiday Inn Kensington Forum, London UK

Building on the sell-out success of the launch event, SMi Group is delighted to announce the return of 3D Cell Culture, taking place on 21st and 22nd of February 2018, in London UK.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement